Literature DB >> 15379140

[Evidence based basis of decision making for or against a postmenopausal hormone treatment].

Eva Rásky1.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15379140     DOI: 10.1007/bf03040940

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  40 in total

Review 1.  The protective effects of estrogen on the cardiovascular system.

Authors:  M E Mendelsohn; R H Karas
Journal:  N Engl J Med       Date:  1999-06-10       Impact factor: 91.245

2.  Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale.

Authors: 
Journal:  Ann Intern Med       Date:  2002-11-19       Impact factor: 25.391

Review 3.  American women's health care. A patchwork quilt with gaps.

Authors:  C M Clancy; C T Massion
Journal:  JAMA       Date:  1992-10-14       Impact factor: 56.272

4.  Hormone replacement therapy, heart disease, and other considerations.

Authors:  E Barrett-Connor; D Grady
Journal:  Annu Rev Public Health       Date:  1998       Impact factor: 21.981

5.  Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review.

Authors:  A MacLennan; S Lester; V Moore
Journal:  Climacteric       Date:  2001-03       Impact factor: 3.005

Review 6.  Hormone replacement therapy and cognition: systematic review and meta-analysis.

Authors:  E S LeBlanc; J Janowsky; B K Chan; H D Nelson
Journal:  JAMA       Date:  2001-03-21       Impact factor: 56.272

7.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

Authors: 
Journal:  Control Clin Trials       Date:  1998-02

8.  Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.

Authors:  Jane A Cauley; John Robbins; Zhao Chen; Steven R Cummings; Rebecca D Jackson; Andrea Z LaCroix; Meryl LeBoff; Cora E Lewis; Joan McGowan; Joan Neuner; Mary Pettinger; Marcia L Stefanick; Jean Wactawski-Wende; Nelson B Watts
Journal:  JAMA       Date:  2003-10-01       Impact factor: 56.272

9.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

10.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Authors:  Sally A Shumaker; Claudine Legault; Stephen R Rapp; Leon Thal; Robert B Wallace; Judith K Ockene; Susan L Hendrix; Beverly N Jones; Annlouise R Assaf; Rebecca D Jackson; Jane Morley Kotchen; Sylvia Wassertheil-Smoller; Jean Wactawski-Wende
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.